These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7512112)

  • 21. Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Woodman N; Pinder SE; Tajadura V; Le Bourhis X; Gillett C; Delannoy P; Burchell JM; Julien S
    Int J Oncol; 2016 Jul; 49(1):265-75. PubMed ID: 27176937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion.
    Stahn R; Schäfer H; Kernchen F; Schreiber J
    Glycobiology; 1998 Apr; 8(4):311-19. PubMed ID: 9499378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selectins induced by interleukin-1beta on the human liver endothelial cells act as ligands for sialyl Lewis X-expressing human colon cancer cell metastasis.
    Matsushita Y; Kitajima S; Goto M; Tezuka Y; Sagara M; Imamura H; Tanabe G; Tanaka S; Aikou T; Sato E
    Cancer Lett; 1998 Nov; 133(2):151-60. PubMed ID: 10072164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of sLex associated with poor survival in Argentinian colorectal cancer patients.
    Zwenger A; Rabassa M; Demichelis S; Grossman G; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2014 Mar; 29(1):e30-9. PubMed ID: 24425323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.
    Nakamori S; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Kabuto T; Iwanaga T; Matsushita Y; Irimura T
    Cancer Res; 1993 Aug; 53(15):3632-7. PubMed ID: 8101764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 1-acid glycoprotein (AGP): a possible carrier of sialyl lewis X (slewis X) antigen in colorectal carcinoma.
    Croce MV; Sálice VC; Lacunza E; Segal-Eiras A
    Histol Histopathol; 2005 Jan; 20(1):91-7. PubMed ID: 15578427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective expression of sialyl-Lewis x and Lewis a epitopes, putative ligands for L-selectin, on peripheral lymph-node high endothelial venules.
    Paavonen T; Renkonen R
    Am J Pathol; 1992 Dec; 141(6):1259-64. PubMed ID: 1281614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility.
    Costa AF; Senra E; Faria-Ramos I; Teixeira A; Morais J; Pacheco M; Reis CA; Gomes C
    Glycoconj J; 2023 Aug; 40(4):421-433. PubMed ID: 37074623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach.
    Trinchera M; Malagolini N; Chiricolo M; Santini D; Minni F; Caretti A; Dall'olio F
    Int J Biochem Cell Biol; 2011 Jan; 43(1):130-9. PubMed ID: 20965272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of sialyl Lewis X-polysaccharide conjugates.
    Sakagami M; Horie K; Nakamoto K; Kawaguchi T; Hamana H
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1256-63. PubMed ID: 10993222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of sialyl Lewis antigen expression in the spread of gastric cancer. Flow cytometric DNA analysis.
    Ashizawa T; Aoki T; Yamazaki T; Katayanagi S; Shimizu H; Koyanagi Y
    J Exp Clin Cancer Res; 2003 Mar; 22(1):91-8. PubMed ID: 12725328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans.
    Mare L; Trinchera M
    Eur J Biochem; 2004 Jan; 271(1):186-94. PubMed ID: 14686931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
    Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
    Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An sLex-deficient variant of HL60 cells exhibits high levels of adhesion to vascular selectins: further evidence that HECA-452 and CSLEX1 monoclonal antibody epitopes are not essential for high avidity binding to vascular selectins.
    Wagers AJ; Stoolman LM; Craig R; Knibbs RN; Kansas GS
    J Immunol; 1998 May; 160(10):5122-9. PubMed ID: 9590264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases.
    Puoti C; Bellis L; Guarisco R; Costanza OM; Felici R; Spilabotti L; Paglia F; Galossi A; Dell' Unto O
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1847-51. PubMed ID: 19686414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer.
    Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Kameyama M; Suehiro S
    Ann Thorac Surg; 2007 Jan; 83(1):216-21. PubMed ID: 17184666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A facile and regioselective synthesis of partially benzoylated 3',4'-O-isopropylidene-beta-lactosides as standardized key intermediates for sialyl Lewis X (sLex) analogues.
    Nashed MA; Musser JH
    Carbohydr Res; 1993 Dec; 250(2):C1-4. PubMed ID: 7907528
    [No Abstract]   [Full Text] [Related]  

  • 39. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.
    Matsushita Y; Cleary KR; Ota DM; Hoff SD; Irimura T
    Lab Invest; 1990 Dec; 63(6):780-91. PubMed ID: 1979361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between sialyl Lewis(a) expression and tumor progression in melanoma.
    Kageshita T; Hirai S; Kimura T; Hanai N; Ohta S; Ono T
    Cancer Res; 1995 Apr; 55(8):1748-51. PubMed ID: 7712483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.